Pepgen Inc (PEPG)

01:01 AM

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PepGen Inc. (PEPG) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

01:01 AM

08:36 AM

Is PepGen Inc. trending in predictive chart modelsTrade Performance Summary & Safe Swing Trade Setups - newser.com

08:36 AM

06:08 AM

Why PepGen Inc. stock remains resilientEarnings Overview Report & Long Hold Capital Preservation Plans - newser.com

06:08 AM

05:21 AM

Is PepGen Inc. stock poised for growthWeekly Risk Summary & Daily Price Action Insights - newser.com

05:21 AM

04:42 AM

Is PepGen Inc. reversing from oversold territoryWeekly Investment Report & AI Optimized Trade Strategies - newser.com

04:42 AM

Oct 03, 2025

PepGen says FREEDOM clinical study achieves all key objectives - MSN

Oct 03, 2025

Oct 03, 2025

What data driven models say about PepGen Inc.’s futureWeekly Gains Report & Daily Profit Focused Screening - newser.com

Oct 03, 2025

Oct 03, 2025

Can trapped investors hope for a rebound in PepGen Inc.Earnings Beat & Safe Swing Trade Setups - newser.com

Oct 03, 2025

Oct 03, 2025

Using Bollinger Bands to evaluate PepGen Inc.2025 AllTime Highs & Accurate Entry/Exit Alerts - newser.com

Oct 03, 2025

Oct 03, 2025

Can momentum traders help lift PepGen Inc.Market Growth Summary & Verified Entry Point Detection - newser.com

Oct 03, 2025

Oct 03, 2025

Is PepGen Inc. stock gaining market shareJuly 2025 Recap & Pattern Based Trade Signal System - newser.com

Oct 03, 2025

Oct 02, 2025

PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle So - PharmiWeb.com

Oct 02, 2025

Oct 02, 2025

PepGen Announces Oral Presentations at the 30th Annual International Congress of the World Muscle Society - Business Wire

Oct 02, 2025

Oct 01, 2025

Major Stakeholder Makes Bold Move with PepGen Inc. Stock Purchase! - TipRanks

Oct 01, 2025

Oct 01, 2025

PepGen Highlights Progress in Therapy for DM1 - TipRanks

Oct 01, 2025

Oct 01, 2025

PepGen Inc. Stock (PEPG) Opinions on Recent Insider Buying and Offering Closure - Quiver Quantitative

Oct 01, 2025

Oct 01, 2025

PepGen Inc. (PEPG) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Oct 01, 2025

Sep 30, 2025

Massive Investment Alert: PepGen Inc. Stock Sees Major Buy-In! - TipRanks

Sep 30, 2025

Sep 30, 2025

Anaphylaxis drives Larimar’s setback, weak efficacy behind MoonLake’s: Clinical Report - BioCentury

Sep 30, 2025

Sep 30, 2025

PepGen Inc. (PEPG) Rating Upgraded With 135% Upside on FREEDOM Data - Insider Monkey

Sep 30, 2025

Sep 30, 2025

PepGen (PEPG) Price Target Increased by 21.95% to 8.50 - Nasdaq

Sep 30, 2025

Sep 30, 2025

Wedbush Cuts Price Target on PepGen to $8 From $9, Keeps Outperform Rating - MarketScreener

Sep 30, 2025

Sep 30, 2025

What analysts say about PepGen Inc stockInstitutional Buying Trends & Follow Top Performers in the Community - earlytimes.in

Sep 30, 2025

Sep 29, 2025

PepGen Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters Option to Purchase Additional Shares - MarketScreener

Sep 29, 2025

Sep 29, 2025

Top Biotech Stocks To Watch TodaySeptember 25th - MarketBeat

Sep 29, 2025

Sep 29, 2025

What is Wedbush’s Estimate for PepGen FY2028 Earnings? - Defense World

Sep 29, 2025

Sep 27, 2025

PepGen Stock Plummets on Secondary Offering News - timothysykes.com

Sep 27, 2025

Sep 27, 2025

A Look at PepGen (PEPG) Valuation After Positive Clinical Data and $100M Equity Raise - Yahoo Finance

Sep 27, 2025

Sep 27, 2025

PepGen Inc. Announces Public Offering Agreement - The Globe and Mail

Sep 27, 2025

Sep 26, 2025

PepGen raises $115 million in public offering to fund clinical trials - Investing.com Nigeria

Sep 26, 2025

Sep 26, 2025

PEPG News Today | Why did PepGen stock drop today? - MarketBeat

Sep 26, 2025

Sep 26, 2025

MBX, uniQure among biotechs raising nine-figure sums: Public Equity Report - BioCentury

Sep 26, 2025